14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ATRA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Atara Biotherapeutics stock upgraded from Sell Candidate to Hold/Accumulate after Tuesday trading session.
(Updated on Apr 23, 2024)

Hold candidate since Apr 23, 2024 PDF

The Atara Biotherapeutics stock price gained 3.04% on the last trading day (Tuesday, 23rd Apr 2024), rising from $0.697 to $0.719. During the last trading day the stock fluctuated 8.69% from a day low at $0.666 to a day high of $0.724. The price has fallen in 6 of the last 10 days and is down by -4.1% for this period. Volume fell on the last day by -19 thousand shares and in total, 831 thousand shares were bought and sold for approximately $597.26 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.58% during the next 3 months and, with a 90% probability hold a price between $0.418 and $1.01 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ATRA Signals & Forecast

The Atara Biotherapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.692 and $0.700. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, February 02, 2024, and so far it has fallen -41.10%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Atara Biotherapeutics stock

Atara Biotherapeutics finds support from accumulated volume at $0.700 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0579 between high and low, or 8.69%. For the last week the stock has had daily average volatility of 8.15%.

Our recommended stop-loss: $0.679 (-5.50%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 55 days ago.)

Trading Expectations (ATRA) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Atara Biotherapeutics to open at $0.703, and during the day (based on 14 day Average True Range), to move between $0.654 and $0.783, which gives a possible trading interval of +/-$0.0645 (+/-8.98%) up or down from last closing price. If Atara Biotherapeutics takes out the full calculated possible swing range there will be an estimated 17.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.700 (2.59%) than the resistance at $0.762 (5.97%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Atara Biotherapeutics stock A Buy?

Atara Biotherapeutics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.431 Hold/Accumulate Upgraded

Predicted Opening Price for Atara Biotherapeutics of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$0.703 ( 2.16%) $0.719

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ATRA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.761 5.90 %
R2 0.739 2.82 %
R1 0.725 0.92 %
Current price: 0.719
Support S1 0.681 -5.23 %
S2 0.667 -7.14 %
S3 0.645 -10.21 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.83 15.50 %
R2 0.778 8.27 %
R1 0.762 5.97 %
Current price 0.719
Support S1 0.700 -2.59%
S2 0.692 -3.77%
S3 0.661 -8.02%

FAQ

What is the symbol for Atara Biotherapeutics Stock and on which exchange is it traded?
The symbol for Atara Biotherapeutics is ATRA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Atara Biotherapeutics Stock?
Atara Biotherapeutics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Atara Biotherapeutics Stock?
Atara Biotherapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Atara Biotherapeutics Stock.

What's the current price of Atara Biotherapeutics Stock?
As of the end of day on the Apr 23, 2024, the price of an Atara Biotherapeutics (ATRA) share was $0.719.

What is the 52-week high and low for Atara Biotherapeutics Stock?
The 52-week high for Atara Biotherapeutics Stock is $3.02 and the 52-week low is $0.199.

What is the market capitalization of Atara Biotherapeutics Stock?
As of the Apr 23, 2024, the market capitalization of Atara Biotherapeutics is 83.241M.

When is the next earnings date for Atara Biotherapeutics?
The upcoming earnings date for Atara Biotherapeutics is May 13, 2024.
Click to get the best stock tips daily for free!

About Atara Biotherapeutics

Atara Biotherapeutics Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i... ATRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT